Literature DB >> 30037313

Protecting Mothers and Babies - A Delicate Balancing Act.

Sonja A Rasmussen1, Wanda Barfield1, Margaret A Honein1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30037313     DOI： 10.1056/NEJMp1809688

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.

Authors:  Caitlin M Dugdale; Andrea L Ciaranello; Linda-Gail Bekker; Madeline E Stern; Landon Myer; Robin Wood; Paul E Sax; Elaine J Abrams; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Ann Intern Med       Date:  2019-04-02       Impact factor: 25.391

2.  Plague and Pregnancy: Why Special Considerations Are Needed.

Authors:  Dana Meaney-Delman; Nadia L Oussayef; Margaret A Honein; Christina A Nelson
Journal:  Clin Infect Dis       Date:  2020-05-21       Impact factor: 9.079

Review 3.  Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action.

Authors:  Melanie M Taylor; Loulou Kobeissi; Caron Kim; Avni Amin; Anna E Thorson; Nita B Bellare; Vanessa Brizuela; Mercedes Bonet; Edna Kara; Soe Soe Thwin; Hamsadvani Kuganantham; Moazzam Ali; Olufemi T Oladapo; Nathalie Broutet
Journal:  Lancet Glob Health       Date:  2020-12-16       Impact factor: 26.763

4.  Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.

Authors:  Gerson Fernando Mendes Pereira; Ahra Kim; Emilia M Jalil; Fernanda Fernandes Fonseca; Bryan E Shepherd; Valdilea G Veloso; Fernanda Rick; Rachel Ribeiro; Maria Cristina Pimenta; Andrea Beber; Renato Girade Corrêa; Renato Lima; Fernanda Maruri; Catherine C McGowan; Adele Schwartz Benzaken; Beatriz Grinsztejn; Jessica L Castilho
Journal:  Lancet HIV       Date:  2021-01       Impact factor: 12.767
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.